Mycio Wealth Partners buys $10,144,209 stake in DENTSPLY International (XRAY)

DENTSPLY International (XRAY) : Mycio Wealth Partners scooped up 392 additional shares in DENTSPLY International during the most recent quarter end , the firm said in a disclosure report filed with the SEC on Aug 10, 2016. The investment management firm now holds a total of 166,244 shares of DENTSPLY International which is valued at $10,144,209.DENTSPLY International makes up approximately 1.70% of Mycio Wealth Partners’s portfolio.

Other Hedge Funds, Including , Ironsides Asset Advisors added XRAY to its portfolio by purchasing 6,905 company shares during the most recent quarter which is valued at $421,343. DENTSPLY International makes up approx 0.12% of Ironsides Asset Advisors’s portfolio. First Personal Financial Services added XRAY to its portfolio by purchasing 692 company shares during the most recent quarter which is valued at $42,143. DENTSPLY International makes up approx 0.01% of First Personal Financial Services’s portfolio.Retirement Systems Of Alabama reduced its stake in XRAY by selling 3,559 shares or 2.89% in the most recent quarter. The Hedge Fund company now holds 119,414 shares of XRAY which is valued at $7,474,122. DENTSPLY International makes up approx 0.04% of Retirement Systems Of Alabama’s portfolio. Eqis Capital Management sold out all of its stake in XRAY during the most recent quarter. The investment firm sold 3,677 shares of XRAY which is valued $230,805.

DENTSPLY International opened for trading at $59.88 and hit $60.81 on the upside on Friday, eventually ending the session at $60.77, with a gain of 1.27% or 0.76 points. The heightened volatility saw the trading volume jump to 13,36,211 shares. Company has a market cap of $14,160 M.

On the company’s financial health, DENTSPLY International reported $0.76 EPS for the quarter, beating the analyst consensus estimate by $ 0.06 according to the earnings call on Aug 5, 2016. Analyst had a consensus of $0.70. The company had revenue of $1022.00 million for the quarter, compared to analysts expectations of $1028.82 million. The company’s revenue was up 46.4% compared to the same quarter last year. During the same quarter in the previous year, the company posted $0.73 EPS.

Many Wall Street Analysts have commented on DENTSPLY International. DENTSPLY International was Downgraded by Barrington Research to ” Mkt Perform” on Aug 8, 2016. DENTSPLY International was Initiated by Piper Jaffray to “Overweight” on Jun 13, 2016. Company shares were Reiterated by Barrington Research on May 13, 2016 to “Outperform”, Firm has raised the Price Target to $ 68 from a previous price target of $62 .

DENTSPLY International Inc. is a designer developer manufacturer and marketer of a range of consumable dental products for the professional dental market. It operates through three segments: Dental Consumable and Certain International Businesses; Dental Specialty and Laboratory and Certain Global Distribution Businesses and Healthcare and Emerging Markets Businesses. All the segments are primarily engaged in the design manufacture and distribution of dental and medical products in four product categories. Its Dental Consumable Products consist of dental supplies and devices and small equipment used in dental offices. Its Dental Laboratory Products are used in the preparation of dental appliances by dental laboratories. Its Dental Specialty Products are specialized treatment products used within the dental office and laboratory settings. Its Consumable Medical Device Products consist mainly of urology catheters certain surgical products medical drills and other products.

Leave a Reply

DENTSPLY International - Is it time to Sell?

Top Brokerage Firms are advising their investors on DENTSPLY International. Subscribe to MoneyFlowIndex.Org Pre-Market Alerts, You will be the first to know the street buzz.